Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2008 3
2010 2
2011 5
2012 6
2013 7
2014 11
2015 6
2016 7
2017 7
2018 7
2019 6
2020 11
2021 28
2022 25
2023 22
2024 4

Text availability

Article attribute

Article type

Publication date

Search Results

140 results

Results by year

Filters applied: . Clear all
Page 1
Pembrolizumab for Early Triple-Negative Breast Cancer.
Schmid P, Cortes J, Pusztai L, McArthur H, Kümmel S, Bergh J, Denkert C, Park YH, Hui R, Harbeck N, Takahashi M, Foukakis T, Fasching PA, Cardoso F, Untch M, Jia L, Karantza V, Zhao J, Aktan G, Dent R, O'Shaughnessy J; KEYNOTE-522 Investigators. Schmid P, et al. N Engl J Med. 2020 Feb 27;382(9):810-821. doi: 10.1056/NEJMoa1910549. N Engl J Med. 2020. PMID: 32101663 Clinical Trial.
Event-free Survival with Pembrolizumab in Early Triple-Negative Breast Cancer.
Schmid P, Cortes J, Dent R, Pusztai L, McArthur H, Kümmel S, Bergh J, Denkert C, Park YH, Hui R, Harbeck N, Takahashi M, Untch M, Fasching PA, Cardoso F, Andersen J, Patt D, Danso M, Ferreira M, Mouret-Reynier MA, Im SA, Ahn JH, Gion M, Baron-Hay S, Boileau JF, Ding Y, Tryfonidis K, Aktan G, Karantza V, O'Shaughnessy J; KEYNOTE-522 Investigators. Schmid P, et al. Among authors: ferreira m. N Engl J Med. 2022 Feb 10;386(6):556-567. doi: 10.1056/NEJMoa2112651. N Engl J Med. 2022. PMID: 35139274 Clinical Trial.
Trends in the Use of Botanicals in Anti-Aging Cosmetics.
Ferreira MS, Magalhães MC, Oliveira R, Sousa-Lobo JM, Almeida IF. Ferreira MS, et al. Molecules. 2021 Jun 11;26(12):3584. doi: 10.3390/molecules26123584. Molecules. 2021. PMID: 34208257 Free PMC article. Review.
A review in radiomics: Making personalized medicine a reality via routine imaging.
Guiot J, Vaidyanathan A, Deprez L, Zerka F, Danthine D, Frix AN, Lambin P, Bottari F, Tsoutzidis N, Miraglio B, Walsh S, Vos W, Hustinx R, Ferreira M, Lovinfosse P, Leijenaar RTH. Guiot J, et al. Among authors: ferreira m. Med Res Rev. 2022 Jan;42(1):426-440. doi: 10.1002/med.21846. Epub 2021 Jul 26. Med Res Rev. 2022. PMID: 34309893 Free article. Review.
Efficacy and safety of aldosterone synthase inhibition with and without empagliflozin for chronic kidney disease: a randomised, controlled, phase 2 trial.
Tuttle KR, Hauske SJ, Canziani ME, Caramori ML, Cherney D, Cronin L, Heerspink HJL, Hugo C, Nangaku M, Rotter RC, Silva A, Shah SV, Sun Z, Urbach D, de Zeeuw D, Rossing P; ASi in CKD group. Tuttle KR, et al. Lancet. 2024 Jan 27;403(10424):379-390. doi: 10.1016/S0140-6736(23)02408-X. Epub 2023 Dec 15. Lancet. 2024. PMID: 38109916 Clinical Trial.
[New vaccines].
Ferreira M, Leal E, Galhardo J, Mendes C, Soares H, Brito MJ. Ferreira M, et al. Acta Med Port. 2011 Dec;24 Suppl 2:167-74. Epub 2011 Dec 31. Acta Med Port. 2011. PMID: 22849900 Free article. Portuguese.
IgA vasculitis with severe renal manifestation.
Marques Dias J, Ferreira MA, Grilo A, Gonçalves FM. Marques Dias J, et al. Among authors: ferreira ma. BMJ Case Rep. 2022 Jun 7;15(6):e248686. doi: 10.1136/bcr-2021-248686. BMJ Case Rep. 2022. PMID: 35672051
Usage of Synthetic Peptides in Cosmetics for Sensitive Skin.
Resende DISP, Ferreira MS, Sousa-Lobo JM, Sousa E, Almeida IF. Resende DISP, et al. Among authors: ferreira ms. Pharmaceuticals (Basel). 2021 Jul 21;14(8):702. doi: 10.3390/ph14080702. Pharmaceuticals (Basel). 2021. PMID: 34451799 Free PMC article. Review.
140 results